Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $264.05B. Across the group, the median move over the past trading day is +1.07%. Price change over the past year runs from +1.7% to +86.5% across the middle 80 percent of the group, with a median of +7.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% |
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +1.98% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | $260.90B | Mega cap | +1.51% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.